Psoriatic Arthritis: A Review - European Medical Journal

Continue

Psoriatic Arthritis: A Review

Rheumatology
Download PDF
Authors:
*Farrouq Mahmood,1 Philip Helliwell2

1. Rheumatology Specialist Registrar, Dewsbury District Hospital, North Kirklees, UK
2. Consultant and Senior Lecturer in Rheumatology, Faculty of Medicine and Health, University of Leeds, Leeds, UK
*Correspondence to [email protected]

Disclosure:

The authors have declared no conflicts of interest.

Received:
08.03.16
Accepted:
16.06.16
Citation:
EMJ Rheumatol. ;3[1]:114-117. DOI/10.33590/emjrheumatol/10313412. https://doi.org/10.33590/emjrheumatol/10313412.
Keywords:
Psoriatic arthritis (PSA), disease modifying anti-rheumatic drugs (DMARDs), biologics, the classification of psoriatic arthritis (CASPAR), dactylitis, arthritis mutilans, rheumatoid arthritis, tumour necrosis factor alpha (TNF-α)

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Abstract

Psoriatic arthritis is an inflammatory arthritis which affects the skin and musculoskeletal system. If not diagnosed early and treated effectively it can result in joint deformity and disability. Treatments such as oral disease modifying anti-rheumatic drugs and biologic therapy are effective but have side effects which could limit their use in certain individuals. Further research aimed at identifying cases earlier in order to improve outcomes is currently being conducted.

Please view the full content in the PDF above. 

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given